254 related articles for article (PubMed ID: 15466390)
1. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
Kamijo A; Sugaya T; Hikawa A; Okada M; Okumura F; Yamanouchi M; Honda A; Okabe M; Fujino T; Hirata Y; Omata M; Kaneko R; Fujii H; Fukamizu A; Kimura K
Am J Pathol; 2004 Oct; 165(4):1243-55. PubMed ID: 15466390
[TBL] [Abstract][Full Text] [Related]
2. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
Kamijo-Ikemori A; Sugaya T; Matsui K; Yokoyama T; Kimura K
Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
[TBL] [Abstract][Full Text] [Related]
3. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage.
Kamijo A; Kimura K; Sugaya T; Yamanouchi M; Hase H; Kaneko T; Hirata Y; Goto A; Fujita T; Omata M
Kidney Int; 2002 Nov; 62(5):1628-37. PubMed ID: 12371963
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.
Yokoyama T; Kamijo-Ikemori A; Sugaya T; Hoshino S; Yasuda T; Kimura K
Am J Pathol; 2009 Jun; 174(6):2096-106. PubMed ID: 19435794
[TBL] [Abstract][Full Text] [Related]
5. Urinary liver type fatty acid binding protein in diabetic nephropathy.
Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
[TBL] [Abstract][Full Text] [Related]
6. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.
Kamijo-Ikemori A; Sugaya T; Obama A; Hiroi J; Miura H; Watanabe M; Kumai T; Ohtani-Kaneko R; Hirata K; Kimura K
Am J Pathol; 2006 Oct; 169(4):1107-17. PubMed ID: 17003471
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
Zuo N; Suzuki Y; Sugaya T; Osaki K; Kanaguchi Y; Wang L; Tomino Y
Nephrol Dial Transplant; 2011 Jul; 26(7):2127-37. PubMed ID: 21109611
[TBL] [Abstract][Full Text] [Related]
8. Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.
Ichikawa D; Kamijo-Ikemori A; Sugaya T; Shibagaki Y; Yasuda T; Hoshino S; Katayama K; Igarashi-Migitaka J; Hirata K; Kimura K
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F114-21. PubMed ID: 25339700
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
[TBL] [Abstract][Full Text] [Related]
10. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.
Kanaguchi Y; Suzuki Y; Osaki K; Sugaya T; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2011 Nov; 26(11):3465-73. PubMed ID: 21525165
[TBL] [Abstract][Full Text] [Related]
12. [Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein].
Ohta S; Ishimitsu T; Minami J; Ono H; Matsuoka H
Nihon Jinzo Gakkai Shi; 2005; 47(4):437-44. PubMed ID: 15971886
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
Kamijo-Ikemori A; Sugaya T; Sekizuka A; Hirata K; Kimura K
Nephrol Dial Transplant; 2009 Mar; 24(3):788-800. PubMed ID: 18854419
[TBL] [Abstract][Full Text] [Related]
14. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.
Sasaki H; Kamijo-Ikemori A; Sugaya T; Yamashita K; Yokoyama T; Koike J; Sato T; Yasuda T; Kimura K
Nephron Clin Pract; 2009; 112(3):c148-56. PubMed ID: 19390215
[TBL] [Abstract][Full Text] [Related]
15. [L-type fatty acid binding protein (L-FABP) and kidney disease].
Kamijo-Ikemori A; Sugaya T; Kimura K
Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
[TBL] [Abstract][Full Text] [Related]
16. Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury.
Ichikawa D; Kamijo-Ikemori A; Sugaya T; Yasuda T; Hoshino S; Igarashi-Migitaka J; Hirata K; Kimura K
Hypertension; 2012 Oct; 60(4):973-80. PubMed ID: 22926951
[TBL] [Abstract][Full Text] [Related]
17. Urinary fatty acid binding protein in renal disease.
Kamijo-Ikemori A; Sugaya T; Kimura K
Clin Chim Acta; 2006 Dec; 374(1-2):1-7. PubMed ID: 16860300
[TBL] [Abstract][Full Text] [Related]
18. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.
Kamijo A; Kimura K; Sugaya T; Yamanouchi M; Hikawa A; Hirano N; Hirata Y; Goto A; Omata M
J Lab Clin Med; 2004 Jan; 143(1):23-30. PubMed ID: 14749682
[TBL] [Abstract][Full Text] [Related]
19. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
Matsui K; Kamijo-Ikemorif A; Sugaya T; Yasuda T; Kimura K
Am J Pathol; 2011 Mar; 178(3):1021-32. PubMed ID: 21356355
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation.
Ichikawa D; Kamijo-Ikemori A; Sugaya T; Shibagaki Y; Yasuda T; Katayama K; Hoshino S; Igarashi-Migitaka J; Hirata K; Kimura K
Am J Physiol Renal Physiol; 2014 Mar; 306(6):F655-63. PubMed ID: 24431207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
